Douglas B. Johnson, MD, MSCI, on Cutaneous Melanoma: Treatment Updates

April 25, 2024 By The ASCO Post Staff

Douglas B. Johnson, MD, MSCI, of Vanderbilt-Ingram Cancer Center, discusses updated guidelines on the use of neoadjuvant therapy, as well as first- and later-line systemic therapies to treat patients with cutaneous melanoma.

Related Content